The edition · Infectious Diseases
MIC-based susceptibility testing is dependable for the drugs that decide a regimen
Pooled across 1,728 isolates, Sensititre MYCOTB matched reference testing closely for rifampicin and isoniazid and poorly for cycloserine. Plus what modelling says about ring versus community vaccination in a Bundibugyo outbreak, thirty-five years of HIV-1 subtype distribution, and why adjunctive steroids in herpes encephalitis remain unsupported.
The edition in brief
A meta-analysis of 14 studies and 1,728 isolates assessed the Sensititre MYCOTB broth microdilution plate against reference drug susceptibility testing for multidrug-resistant and pre-extensively drug-resistant tuberculosis. Sensitivity and specificity were high and consistent for rifampicin and isoniazid, specificity exceeded 0.98 for amikacin, kanamycin and ofloxacin, and performance was moderate for ethambutol, streptomycin, ethionamide and rifabutin. Cycloserine performed poorly, with pooled sensitivity of 0.436 even after sensitivity analysis. A stochastic network model calibrated to 2026 Bundibugyo virus outbreak data in the Democratic Republic of the Congo found that improving case detection and contact tracing alone cut expected mortality by 81.6%; adding reactive ring vaccination with a hypothetical 45%-effective vaccine added 10.5 percentage points, while community vaccination at 80% coverage reduced mortality by 86.6% at a cost of up to 111 doses per death averted. A systematic review and global survey covering 1,395,222 HIV-1 samples from 154 countries found subtype C responsible for 48.7% of infections worldwide in 2020-24, with distributions regionally distinct and broadly stable since 2000. A meta-analysis of four comparative studies and 209 patients found no evidence that adjunctive corticosteroids improve outcome in herpes simplex virus encephalitis, with all randomised estimates imprecise and compatible with benefit or harm.
Where MIC-based tuberculosis susceptibility testing can be trusted
MIC-based testing with this platform is reliable for rifampicin, isoniazid and the injectables, but a susceptible cycloserine result should not be used to build a regimen.
In a filovirus outbreak, tracing beats vaccinating
Modelling a Bundibugyo outbreak put strengthened case finding and contact tracing ahead of vaccination, with ring vaccination adding only about ten percentage points once operations were strong.
Subtype C is half of global HIV, and the map has not moved much
Subtype C causes about half of HIV-1 infections worldwide and dominates in south Asia, which is a reason to interpret assays validated on subtype B with some caution.
Start aciclovir before the scan, not after the result
Start aciclovir the moment herpes encephalitis is considered, and do not let a normal early scan or a negative early PCR stop it.
Adjunctive steroids in herpes encephalitis: still no evidence to act on
Routine adjunctive corticosteroids in herpes simplex encephalitis have no supporting evidence, and the imprecision of the trials means benefit and harm both remain possible.
Read the rest in the app
You have read your two free briefings this month. The app carries all 27 specialties, every morning, free — and this one is waiting in it.

Scan to keep reading on your phone. No account needed to start.
Tomorrow morning, before your first patient
One edition a day for infectious diseases, written by the desk, every claim tied to its paper. Six minutes.
Get the app — free